The pharmaceutical supply chain is experiencing a critical transition moment. While regulatory compliance timelines have dominated industry conversations, a more immediate challenge is emerging from pharmacy receiving docks across the country: the infrastructure meant to ensure drug traceability is breaking down at the data level.